期刊文献+

脂肪变性对肝细胞胆固醇代谢的影响 被引量:5

Cholesterol metabolism in cultured steatotic hepatocytes
下载PDF
导出
摘要 目的:探讨非酒精性脂肪性肝病中肝细胞胆固醇(TC)代谢的相关变化.方法:正常成人肝细胞株HL-02,以油酸软脂酸诱导肝细胞产生脂肪变性,建立肝细胞脂肪变性模型.分别于实验12、24、48h收集细胞,同期设不含脂肪酸培养的细胞作对照.油红O染色观察细胞内脂滴变化;试剂盒检测细胞内三酯酰甘油(TG)和TC含量的变化情况,RT-PCR分别检测表达固醇调节元件结合蛋白2(SREBP-2),其靶基因羟甲基戊二酸单酰辅酶A还原酶(HMGCR)、低密度脂蛋白受体(LDLR)及TC7α羟化酶(CYP7α1)的基因mRNA变化.结果:油酸软脂酸诱导12h即可产生肝细胞脂肪变性,24h及48h脂肪变性逐渐加重.随造模时间延长,模型组细胞内TG、TC含量逐渐增多,且均显著高于对照组(TG:16.93±1.57mg/g,23.67±2.4mg/g,51.1±11.76mg/gvs8.43±5.65mg/g;TC:14.9±0.6,23.7±1.1mg/g,38.4±4.5mg/gvs8.5±1.6mg/g;均P<0.01);SREBP-2,HMGCRmRNA表达逐渐升高(SREBP-2mRNA:1.2972±0.16,1.6141±0.21,2.0368±0.27vs1.0±0.11;HMGCRmRNA:1.0311±0.15,1.2706±0.28,1.3954±0.32vs1.0±0.12;均P<0.05),而LDLR、CYP7α1mRNA表达逐渐下降(LDLRmRNA:0.8901±0.22,0.7846±0.18,0.6912±0.09vs1.0±0.24;CYP7α1mRNA:0.9726±0.27,0.6707±0.18,0.5659±0.16vs1.0±0.19;均P<0.05).结论:肝细胞脂变后细胞内TC含量增加,其合成基因表达升高及代谢基因表达降低可能是其机制;LDLRmRNA表达降低. AIM: To investigate the changes of cholesterol metabolism in nonalcoholic fatty liver disease. METHODS: Steatosis model of hepatocytes was established by adding palmic acid and oleic acid to HL-02 cells. Cells were collected at 12, 24 and 48 h. HL-02 cells without adding palmic acid served as controls. Oil red O staining was used to observe the intracellular changes of lipid drops. The intracellular triglyceride (TG) and total cholesterol were detected using analysis kit. The expression changes of sterol regulatory element-binding protein 2 (SREBP-2), hydroxy- methylglutaryl-CoA reductase (HMGCR), low density lipoprotein receptor (LDLR) and cholesterol 7alpha-hydroxylase (CYP7A1) were measured by reverse transcription-polymerase chain reaction (RT-PCR). RESULTS: Hepatocyte steatosis was observedat 12 h, and became more serious at 24 and 48 h. The contents of intracellular TG and TC in- creased, significantly higher than those in con- trois (TG: 16.93 + 1.57 mg/g, 23.67 + 2.4 mg/g, 51.1 + 11.76 mg/g vs 8.43 + 5.65 mg/g; TC: 14.9 + 0.6 mg/g, 23.7 + 1.1 mg/g, 38.4 + 4.5 mg/g vs 8.5 + 1.6 mg/g, all P 〈 0.01). The expression lev- els of SREBP-2 and HMGCR were up-regulated (SREBP-2 mRNA: 1.2972 + 0.16, 1.6141 + 0.21, 2.0368 + 0.27 vs 1.0 + 0.11; HMGCR mRNA: 1.0311 + 0.15, 1.2706 + 0.28, 1.3954 + 0.32 vs 1.0 + 0.12; all P 〈 0.05) while those of LDLR and CYP7A1 (LDLR n^d~qA: 0.8901 + 0.22, 0.7846 + 0.18, 0.6912 + 0.09 vs 1.0 + 0.24; CYP7al mRNA: 0.9726 + 0.27, 0.6707 + 0.18, 0.5659 + 0.16 vs 1.0 + 0.19; all P 〈 0.05) were down-regulated in a time-dependent manner in model group. CONCLUSION: Cholesterol contents increase in steatotic hepatocytes, which may be caused by elevated gene expression of SREBP-2 and HMGCR as well as reduced expression of LDLR and CYP7A1.
出处 《世界华人消化杂志》 CAS 北大核心 2008年第10期1031-1036,共6页 World Chinese Journal of Digestology
关键词 肝细胞脂肪变性 三酯酰甘油 胆固醇 逆转录-聚合酶链反应 Hepatocyte steatosis Triglyceride Cho-lesterol Reverse transcriptase polymerase chainreaction
  • 相关文献

参考文献32

  • 1Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850
  • 2Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37: 1202-1219
  • 3Arslan U, Türko?lu S, Balcioglu S, Tavil Y, Karakan T, Cengel A. Association between nonalcoholic fatty liver disease and coronary artery disease. Coron Artery Dis 2007; 18: 433-436
  • 4Targher G. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabet Med 2007; 24: 1-6
  • 5Gómez-Lechón MJ, Donato MT, Martínez-Romero A, Jiménez N, Castell JV, O'Connor JE. A human hepatocellular in vitro model to investigate steatosis. Chem Biol Interact 2007; 165: 106-116
  • 6Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007; 191: 235-240
  • 7Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J 3rd. Factors of risk in the development of coronary heart disease-six year follow-up experience. The Framingham Study. Ann Intern Med 1961; 55: 33-50
  • 8Rader DJ. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med 2007; 120: S12-S18
  • 9Bansilal S, Farkouh ME, Fuster V. Role of insulin resistance and hyperglycemia in the development of atherosclerosis. Am J Cardiol 2007; 99: 6B-14B
  • 10Cupp D, Kampf JP, Kleinfeld AM. Fatty acid-albumin complexes and the determination of the transport of long chain free fatty acids across membranes. Biochemistry 2004; 43: 4473-4481

同被引文献62

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部